Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial-Reference-Cited by-同舟云学术

Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial

Published:2024-08-20 Issue:1 Volume:24 Page:
ISSN:1471-2431
Container-title:BMC Pediatrics
language:en
Short-container-title:BMC Pediatr

Author:

Al-Baiaty Farah D. R.,Ishak Shareena,Mohd Zaki Faizah,Masra Farin,Abdul Aziz Dayang Anita,Wan Md Zin Wan Nurulhuda,Yee Hing Erica,Kuthubul Zaman Azrina Syarizad,Abdul Wahab Norhazlina,Muhammad Nawawi Khairul Najmi,Hamid Zalina,Raja Ali Raja Affendi,Mokhtar Norfilza Mohd

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12887-024-04993-8.pdf

Reference66 articles.

1. Marcinkiewicz K, Horodnicka-Józwa A, Jackowski T, Strączek K, Biczysko-Mokosa A, Walczak M, Petriczko E. Nonalcoholic fatty liver disease in children with obesity–observations from one clinical centre in the Western Pomerania region. Front Endocrinol. 2022;13: 992264.

2. Phen C, Ramirez CM. Hepatic steatosis in the pediatric population: an overview of pathophysiology, genetics, and diagnostic workup. Clin Liver Dis. 2021;17(3):191.

3. Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity. BMC Pediatr. 2021;21(1):1–8.

4. Ranucci G, Spagnuolo MI, Iorio R. Obese children with fatty liver: between reality and disease mongering. World J Gastroenterol. 2017;23(47): 8277.

5. Li J, Ren W. Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children. Zhonghua gan Zang Bing za zhi= Zhonghua Ganzangbing Zazhi= Chinese. J Hepatol. 2020;28(3):208–12.